World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
86
Citations
29959
World Ranking
14034
National Ranking
1299

Giancarlo Viberti publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Giancarlo Viberti sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 325 publications — 22nd percentile

22% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Giancarlo Viberti D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Giancarlo Viberti sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 86 D-Index — 31st percentile

31% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Giancarlo Viberti is affiliated with King's College London in the United Kingdom. Their research primarily focuses on Medicine, with specialization in Cardiology and Cardiovascular Medicine as well as Endocrinology, Diabetes, and Metabolism.

Their recent work includes several papers published in prominent journals. These publications include:

  • Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis (2021, The Lancet)
  • Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis (2021, The Lancet)
  • Blood pressure lowering in isolated diastolic hypertension and cardiovascular risk: an individual patient data meta-analysis (2025, European Heart Journal)
  • P.64 Active Vitamin D Treatment Does Not Improve Arterial Stiffness and Markers of Cardio-Renal Risk in Patients with Type 2 Diabetes and Stage 3 Chronic Kidney Disease: a Randomised Controlled Trial (2020, Artery Research)

The main topics covered in their work are:

  • Blood Pressure and Hypertension Studies
  • Heart Rate Variability and Autonomic Control
  • Cardiac Health and Mental Health
  • Hormonal Regulation and Hypertension

Frequent co-authors collaborating with Giancarlo Viberti include:

  • Kazem Rahimi
  • Zeinab Bidel
  • Milad Nazarzadeh
  • Dexter Canoy
  • Mark Woodward

Their research is often published in venues such as:

  • The Lancet
  • European Heart Journal
  • Artery Research

This profile highlights Giancarlo Viberti's focus on cardiovascular research, particularly related to blood pressure management and the interplay between cardiac and metabolic health. Their contributions include collaborative meta-analyses and clinical trials that explore pharmacological and biochemical interventions in these fields.

Best Publications

  • Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.

    Kahn Se;Haffner Sm;Heise Ma;Herman Wh

  • Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes

    Hermann Haller;Sadayoshi Ito;Joseph L. Izzo;Andrzej Januszewicz

  • Microalbuminuria Reduction With Valsartan in Patients With Type 2 Diabetes Mellitus A Blood Pressure–Independent Effect

    Giancarlo Viberti;Nigel M. Wheeldon

  • Prevention of diabetic renal disease with special reference to microalbuminuria

    Carl Erik Mogensen;William F. Keane;Peter H. Bennett;George Jerums

  • Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria

    G Viberti;C E Mogensen;L C Groop;J F Pauls

  • Rosiglitazone-associated Fractures in Type 2 Diabetes: An Analysis From A Diabetes Outcome Progression Trial (ADOPT)

    Steven E. Kahn;Bernard Zinman;John M. Lachin;Steven M. Haffner

  • Prospective study of microalbuminuria as predictor of mortality in NIDDM.

    Martin B Mattock;Nicholas J Morrish;Giancarlo Viberti;Harry Keen

  • Avosentan for Overt Diabetic Nephropathy

    Johannes F.E. Mann;Damian Green;Kenneth Jamerson;Luis M. Ruilope

  • Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis

    Kazem Rahimi;Zeinab Bidel;Milad Nazarzadeh;Emma Copland

  • Increased sodium-lithium countertransport activity in red cells of patients with insulin-dependent diabetes and nephropathy

    Ruggero Mangili;Jeremy J. Bending;Graham Scott;Lai K. Li

  • Effect of control of blood glucose on urinary excretion of albumin and beta2 microglobulin in insulin-dependent diabetes.

    Viberti Gc;Pickup Jc;Jarrett Rj;Keen H

  • Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: A twenty-three year follow-up study

    J W Messent;T G Elliott;R D Hill;R J Jarrett

  • Podocyte Number in Normotensive Type 1 Diabetic Patients With Albuminuria

    Kathryn E. White;Rudolf W. Bilous;Sally M. Marshall;Meguid El Nahas

  • A Diabetes Outcome Progression Trial (ADOPT) An international multicenter study of the comparative efficacy of rosiglitazone, glyburide, and metformin in recently diagnosed type 2 diabetes

    Giancarlo Viberti;Steven E. Kahn;Douglas A. Greene;William H. Herman

  • Rosiglitazone reduces urinary albumin excretion in type II diabetes.

    G Bakris;G Viberti;W M Weston;M Heise

  • Pathogenesis of diabetic nephropathy.

    A E Raptis;Gian-Carlo Viberti

  • Insulin resistance in insulin-dependent diabetic patients with microalbuminuria

    J. Yip;M. B. Mattock;A. Morocutti;Meera Sethi

  • Effect of Low-Dose Perindopril/Indapamide on Albuminuria in Diabetes Preterax in Albuminuria Regression: PREMIER

    Carl Erik Mogensen;Giancarlo Viberti;Serge Halimi;Eberhard Ritz

  • Familial Clustering of Cardiovascular Disease in Patients with Insulin-Dependent Diabetes and Nephropathy

    Kenneth Earle;James Walker;Caron Hill;GianCarlo Viberti

  • The Endothelin Antagonist Atrasentan Lowers Residual Albuminuria in Patients with Type 2 Diabetic Nephropathy

    Dick De Zeeuw;Blai Coll;Dennis Andress;John J. Brennan

Frequent Co-Authors

Harry Keen
Harry Keen Guy's Hospital
Eberhard Ritz
Eberhard Ritz Heidelberg University
Rury R. Holman
Rury R. Holman University of Oxford
Luis M. Ruilope
Luis M. Ruilope European University of Madrid
Steven E. Kahn
Steven E. Kahn University of Washington
Hermann Haller
Hermann Haller Hannover Medical School
Ton J. Rabelink
Ton J. Rabelink Leiden University Medical Center
Giuseppe Remuzzi
Giuseppe Remuzzi Mario Negri Institute for Pharmacological Research
John M. Lachin
John M. Lachin George Washington University
Bernard Zinman
Bernard Zinman University of Toronto

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Medicine in the USA offers many alternative pathways for those seeking flexibility or looking to advance their careers online. Healthcare professionals can now pursue an online mha program to move into administrative and leadership roles without disrupting their work schedule. These programs are designed for convenience, letting you balance professional and academic demands.

For registered nurses interested in earning a bachelor’s degree, there are now rn to bsn with no clinicals options, allowing RNs to study online and complete their education without additional on-site clinical requirements.

Advanced practice nurses who want to further their education quickly can choose accelerated msn to dnp programs, which fast-track doctoral training in nursing.

Additionally, for those seeking a smooth transition to doctoral-level nursing, there are dnp programs that are designed for efficiency and accessibility.

These pathways make it easier than ever to grow in the healthcare field, offering flexible and reputable online credentials.

Best Scientists Citing Giancarlo Viberti

Trending Scientists

Recently Published Articles